Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Lymphopenia”

111 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 111 results

Testing effectiveness (Phase 2)UnknownNCT03019809
What this trial is testing

A Trial of Plerixafor/G-CSF as Additional Agents for Conditioning Before TCR Alpha/Beta Depleted HSCT in WAS Patients

Who this might be right for
Wiskott-Aldrich SyndromeHematopoietic Stem Cell TransplantationGraft Failure
Federal Research Institute of Pediatric Hematology, Oncology and Immunology 30
Not applicableWithdrawnNCT01660347
What this trial is testing

Donor Stem Cell Boost in Treating Patients With Low Blood Cells After Donor Stem Cell Transplant

Who this might be right for
AnemiaHematopoietic/Lymphoid CancerLymphopenia+2 more
Sidney Kimmel Cancer Center at Thomas Jefferson University
Not applicableStudy completedNCT06968156
What this trial is testing

The Effect of Monocyte Values Accompanied by Lymphopenia on the Prognosis of Patients Diagnosed With COVID-19

Who this might be right for
COVID 19Lymphopenia Due to COVID-19Monocyte
Kanuni Sultan Suleyman Training and Research Hospital 200
Testing effectiveness (Phase 2)Ended earlyNCT00909363
What this trial is testing

Thrombocytopenia and Bleeding in Wiskott-Aldrich Syndrome (WAS) Patients

Who this might be right for
Wiskott-Aldrich SyndromeThrombocytopeniaBleeding
Weill Medical College of Cornell University 24
Testing effectiveness (Phase 2)Ended earlyNCT04426201
What this trial is testing

InterLeukin-7 to Improve Clinical Outcomes in Lymphopenic Patients With COVID-19 Infection ( ILIAD-7-US-O )

Who this might be right for
COVID-19Lymphocytopenia
Revimmune 10
Not applicableStudy completedNCT01653834
What this trial is testing

Feasibility of Lymphocyte Reinfusion in Newly Diagnosed High Grade Gliomas

Who this might be right for
Glioblastoma
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins 10
Large-scale testing (Phase 3)Study completedNCT00220766
What this trial is testing

Rapid Infusion of Immune Globulin Intravenous (Human) In Primary Immunodeficiency Patients

Who this might be right for
Immunologic Deficiency SyndromeAgammaglobulinemiaSevere Combined Immunodeficiency+2 more
Grifols Therapeutics LLC 100
Testing effectiveness (Phase 2)Enrolling By InvitationNCT01852370
What this trial is testing

Sequential Cadaveric Lung and Bone Marrow Transplant for Immune Deficiency Diseases

Who this might be right for
Severe Combined Immunodeficiency (SCID)Immunodeficiency With Predominant T-cell Defect, UnspecifiedSevere Chronic Neutropenia+6 more
Paul Szabolcs 16
Testing effectiveness (Phase 2)Ended earlyNCT02512679
What this trial is testing

Related Hematopoietic Stem Cell Transplantation (HSCT) for Genetic Diseases of Blood Cells

Who this might be right for
Stem Cell TransplantationBone Marrow TransplantationPeripheral Blood Stem Cell Transplantation+10 more
Children's Hospital Los Angeles 20
Testing effectiveness (Phase 2)Looking for participantsNCT07258160
What this trial is testing

Evaluation of the Effect of Cordycepin on CD8+ Lymphocytopenia in Patients With Solid Tumors

Who this might be right for
Solid CancerLymphopenia
Second Affiliated Hospital of Soochow University 127
Testing effectiveness (Phase 2)Study completedNCT01347242
What this trial is testing

Gene Therapy for Wiskott-Aldrich Syndrome (WAS)

Who this might be right for
Wiskott-Aldrich Syndrome
Genethon 6
Not applicableUnknownNCT02803346
What this trial is testing

Evaluation of Immunosuppression in Septic Shock: Biomarkers and Pharmacological Restoration (IMMUNOSEPSIS)

Who this might be right for
Immunology of Septic Shock
Hospices Civils de Lyon 160
Not applicableStudy completedNCT04429568
What this trial is testing

THC Crossover Study

Who this might be right for
THCCannabisCannabis Smoking+6 more
University of California, San Francisco 14
Testing effectiveness (Phase 2)Active Not RecruitingNCT02333760
What this trial is testing

Long Term Safety Follow up of Haematopoietic Stem Cell Gene Therapy for the Wiskott Aldrich Syndrome

Who this might be right for
Wiskott-Aldrich Syndrome
Genethon 10
Testing effectiveness (Phase 2)Ended earlyNCT04407689
What this trial is testing

InterLeukin-7 to Improve Clinical Outcomes in Lymphopenic pAtients With COVID-19 Infection FR BL Cohort

Who this might be right for
COVID-19Lymphocytopenia
Revimmune 34
Testing effectiveness (Phase 2)Study completedNCT01515462
What this trial is testing

Gene Therapy for Wiskott-Aldrich Syndrome

Who this might be right for
Wiskott-Aldrich Syndrome (WAS)
Fondazione Telethon 8
Not applicableStudy completedNCT03549546
What this trial is testing

Expression of the Inhibitory Receptors on Lymphocytes T Cells After Lung Cancer Surgery.

Who this might be right for
Lung CancerSurgery
Centre Hospitalier Universitaire de Saint Etienne 31
Not applicableUnknownNCT05300373
What this trial is testing

Evaluation of Adenosine Deaminase (ADA) Enzyme Deficiency in Patients With Lymphopenia and/or Elevated Immunoglobulin E

Who this might be right for
Adenosine Deaminase Deficiency
TRPHARM 100
Not applicableStudy completedNCT03651388
What this trial is testing

Research Into the Molecular Bases of a New Phenotype Combining Premature White Hair, Polycystic Kidney Disease, Aortic Dilation/Dissection and Lymphopenia

Who this might be right for
New Phenotype (Combining Premature White Hair, Polycystic Kidney Disease, Aortic Dilation/Dissection and Lymphopenia)
Centre Hospitalier Universitaire Dijon 4
Testing effectiveness (Phase 2)Ended earlyNCT04668833
What this trial is testing

ALI Post Radiation Therapy in Patients With Lung and Esophageal Canter

Who this might be right for
Solid Tumor Malignancies
M.D. Anderson Cancer Center 26
Load More Results